⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
globenewswire.com
REGN
Pomerantz LLP Alerts Shareholders to Investor Suit Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
$REGN Securities: Suffer Losses on Your Regeneron Investment? BFA Law Reminds Investors of the Securities Fraud Lawsuit to Recover Losses
globenewswire.com
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Join Class Action Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN
REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Class Action Amid Disclosures About Key Trial’s Protocol and Ultimate Failure
globenewswire.com
REGN
September 14, 2026 Deadline Approaching: Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN) - Contact Levi & Korsinsky
accessnewswire.com
REGN
REGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
REGN
Investor Alert: Deadline Approaching to Join Regeneron Pharmaceuticals, Inc. (REGN) Class Action - Contact Levi & Korsinsky
accessnewswire.com
REGN
Class Action Alert: Levi & Korsinsky Reminds Regeneron (REGN) Investors of September 14, 2026 Deadline
accessnewswire.com
REGN